Cargando…

Cardiotoxicity of Mitoxantrone Treatment in a German Cohort of 639 Multiple Sclerosis Patients

BACKGROUND AND PURPOSE: The aim of this study was to elucidate the role of therapy-related cardiotoxicity in multiple sclerosis (MS) patients treated with mitoxantrone and to identify potential predictors for individual risk assessment. METHODS: Within a multicenter retrospective cohort design, card...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fleischer, Vinzenz, Salmen, Anke, Kollar, Susanne, Weyer, Veronika, Siffrin, Volker, Chan, Andrew, Zipp, Frauke, Luessi, Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198709/ https://www.ncbi.nlm.nih.gov/pubmed/25324877 http://dx.doi.org/10.3988/jcn.2014.10.4.289

Ejemplares similares

The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients
por: Droby, Amgad, et al.
Publicado: (2015)

Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS
por: Muthuraman, Muthuraman, et al.
Publicado: (2016)

Network alterations underlying anxiety symptoms in early multiple sclerosis
por: Ellwardt, Erik, et al.
Publicado: (2022)

Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis
por: Chanvillard, Coralie, et al.
Publicado: (2012)

Late Cardiotoxicity in MS Patients Treated with Mitoxantrone
por: Najafian, Jamshid, et al.
Publicado: (2019)

Continuous reorganization of cortical information flow in multiple sclerosis: A longitudinal fMRI effective connectivity study
por: Fleischer, Vinzenz, et al.
Publicado: (2020)

Modulation of Dendritic Cell Immunobiology via Inhibition of 3-Hydroxy-3-Methylglutaryl-CoA (HMG-CoA) Reductase
por: Leuenberger, Tina, et al.
Publicado: (2014)

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort
por: Salmen, Anke, et al.
Publicado: (2023)

Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis
por: Engel, Sinah, et al.
Publicado: (2021)

Inflammation as a Possible Trigger for Mitoxantrone-Induced Cardiotoxicity: An In Vivo Study in Adult and Infant Mice
por: Reis-Mendes, Ana, et al.
Publicado: (2021)

GFAPα IgG-associated encephalitis upon daclizumab treatment of MS
por: Luessi, Felix, et al.
Publicado: (2018)

Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers
por: Brummer, Tobias, et al.
Publicado: (2022)

A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk Factors
por: Engel, Sinah, et al.
Publicado: (2021)

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
por: Fleischer, Vinzenz, et al.
Publicado: (2019)

Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort
por: Steffen, Falk, et al.
Publicado: (2022)

Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosis
por: Seitz, Caspar B., et al.
Publicado: (2021)

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)
por: Johnen, Andreas, et al.
Publicado: (2018)

PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders
por: Engel, Sinah, et al.
Publicado: (2020)

Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis
por: Ciolac, Dumitru, et al.
Publicado: (2019)

Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial
por: Engel, Sinah, et al.
Publicado: (2023)

Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS
por: Engel, Sinah, et al.
Publicado: (2020)

Association of obesity with disease outcome in multiple sclerosis
por: Lutfullin, Isabel, et al.
Publicado: (2023)

Malignancies after mitoxantrone for multiple sclerosis: A retrospective cohort study
por: Buttmann, Mathias, et al.
Publicado: (2016)

Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension
por: Engel, Sinah, et al.
Publicado: (2023)

Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
por: Engel, Sinah, et al.
Publicado: (2022)

A Case of Marburg's Variant of Multiple Sclerosis Successfully Treated with IVIg and Mitoxantrone
por: Manuel, Adarsh, et al.
Publicado: (2021)

Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
por: Zrzavy, Tobias, et al.
Publicado: (2021)

The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis
por: Gracien, René-Maxime, et al.
Publicado: (2016)

Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS
por: Engel, Sinah, et al.
Publicado: (2019)

Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis
por: Ghadiri, Mahtab, et al.
Publicado: (2017)

Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions
por: Wiendl, Heinz, et al.
Publicado: (2021)

Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis”
Publicado: (2021)

MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation
por: Loos, Julia, et al.
Publicado: (2020)

In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity
por: Herz, Josephine, et al.
Publicado: (2011)

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study: Serum NfL predicts relapse-free progression
por: Uphaus, Timo, et al.
Publicado: (2021)

Runs 639, 651 and 656, Tests of the Poleface Windings power supplies
por: Fischer, E, et al.
Publicado: (1976)

Run 639 75-10-11, Vacuum Limit Ring 1
por: Calder, R, et al.
Publicado: (1975)

639. Short Course Therapy for Urinary Tract Infections (SCOUT) in Children
por: Zaoutis, Theoklis, et al.
Publicado: (2020)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
por: Engel, Sinah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ofpbk74du8s33bb4ngk9vfte17